Different Vascular Healing Patterns With Various Drug-Eluting Stents in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Optical Coherence Tomographic Findings

American Journal of Cardiology

Volumn 105, Issue 7, 2010, Pages 972-976

  Fan, Chunyu ^a   Kim, Jung Sun ^b   Lee, Jung Myung ^b   Kim, Tae Hoon ^b   Park, Sang Min ^b   Wi, Jin ^b   Paik, Sung Il ^b   Ko, Young Guk ^b   Choi, Donghoon ^b   Hong, Myeong Ki ^b   Jang, Yangsoo ^b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b Yonsei University Health System   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HEALING; HEART INFARCTION; HUMAN; IMPLANTATION; INTIMA; MALE; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSTHESIS LOOSENING; ST SEGMENT ELEVATION; STENT THROMBOSIS; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; WOUND HEALING;

EID: 77949568899     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.11.018     Document Type: Article

References (16)

1. Nakazawa G., Finn A.V., Joner M., Ladich E., Kutys R., Mont E.K., Gold H.K., Burke A.P., Kolodgie F.D., and Virmani R. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118 (2008) 1138-1145
2. Matsumoto D., Shite J., Shinke T., Otake H., Tanino Y., Ogasawara D., Sawada T., Paredes O.L., Hirata K., and Yokoyama M. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28 (2007) 961-967
3. Yao Z.H., Matsubara T., Inada T., Suzuki Y., and Suzuki T. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography. Chin Med J 121 (2008) 503-507
4. Takano M., Yamamoto M., Inami S., Murakami D., Seimiya K., Ohba T., Seino Y., and Mizuno K. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography. J Am Coll Cardiol 51 (2008) 968-969
5. Takano M., Inami S., Jang I.K., Yamamoto M., Murakami D., Seimiya K., Ohba T., and Mizuno K. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 99 (2007) 1033-1038
6. Finn A.V., Joner M., Nakazawa G., Kolodgie F., Newell J., John M.C., Gold H.K., and Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
7. Guagliumi G., and Sirbu V. Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stenting. Catheter Cardiovasc Interv 72 (2008) 237-247
8. Tanigawa J., Barlis P., and Di Mario C. Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. Euro Interv 3 (2007) 128-136
9. Tanigawa J., Barlis P., Dimopoulos K., Dalby M., Moore P., and Di Mario C. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int J Cardiol 134 (2009) 180-188
10. Kume T., Akasaka T., Kawamoto T., Ogasawara Y., Watanabe N., Toyota E., Neishi Y., Sukmawan R., Sadahira Y., and Yoshida K. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 97 (2006) 1713-1717
11. Sonoda S., Morino Y., Ako J., Terashima M., Hassan A.H.M., Bonneau H.N., Leon M.B., Moses J.W., Yock P.G., Honda Y., Kuntz R.E., Fitzgerald P.J., and SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 43 (2004) 1959-1963
12. Gonzalo N., Barlis P., Serruys P.W., Garcia-Garcia H.M., Onuma Y., Ligthart J., and Regar E. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. J Am Coll Cardiol Interv 2 (2009) 445-452
13. Levin A.D., Vukmirovic N., Hwang C.W., and Edelman E.R. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci USA 101 (2004) 9463-9467
14. Hwang C.W., Levin A.D., Jonas M., Li P.H., and Edelman E.R. Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation 111 (2005) 1619-1626
15. Finn A.V., Nakazawa G., Joner M., Kolodgie F.D., Mont E.K., Gold H.K., and Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
16. Meredith I.T., Ormiston J., Whitbourn R., Kay I.P., Muller D., Popma J.J., Cutlip D.E., Fitzgerald P.J., and ENDEAVOR I Investigators. Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study. Am J Cardiol 100 (2007) 56M-61M